Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -153.61% is 2173% below its 5-year average of -6.76%, near the high end of its 5-year range (-632.75%–0.00%).
38.66% above its 12-month average of -250.44%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -144.26%.
NET PROFIT MARGIN
-153.61%
NET PROFIT MARGIN AVG TTM
-250.44%
NET PROFIT MARGIN AVG 3Y
-57.33%
NET PROFIT MARGIN AVG 5Y
-6.76%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+38.66%
CURRENT VS 3Y AVG
-167.94%
CURRENT VS 5Y AVG
-2172.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 667 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alpha Cognition Inc
Market Cap
$140.40M
Net Profit Margin
-153.61%
TTM Avg
-250.44%
3Y Avg
-57.33%
5Y Avg
-6.76%
Market Cap
$139.73M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$141.44M
Net Profit Margin
-7.79%
TTM Avg
-6.13%
3Y Avg
-5.81%
5Y Avg
-0.54%
Market Cap
$143.10M
Net Profit Margin
-435.70%
TTM Avg
-1104.64%
3Y Avg
-1053.90%
5Y Avg
-4200.61%
Market Cap
$136.88M
Net Profit Margin
-4.03%
TTM Avg
-12.22%
3Y Avg
-25.92%
5Y Avg
-21.35%
Market Cap
$135.41M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$146.30M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3984.32%
5Y Avg
-3047.80%
Market Cap
$147.49M
Net Profit Margin
-353.00%
TTM Avg
-161.48%
3Y Avg
-3791.01%
5Y Avg
-3351.38%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $140.40M | -153.61% | -250.44% | -57.33% | -6.76% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 163.32% | -34.49% | -63.76% | -75.19% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $141.44M | -7.79% | -6.13% | -5.81% | -0.54% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -435.70% | -1104.64% | -1053.90% | -4200.61% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | -4.03% | -12.22% | -25.92% | -21.35% |
| Freenome, Inc. (FRNM)vs › | $134.92M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $135.41M | -10.40% | -6.28% | -16.07% | -47.85% |
| Immuneering Corporation (IMRX)vs › | $146.30M | 0.00% | 0.00% | -3984.32% | -3047.80% |
| Korsana Biosciences, Inc. (KRSA)vs › | $147.49M | -353.00% | -161.48% | -3791.01% | -3351.38% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.54M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-221.7%
Net Profit Margin
-153.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -144.26% |
| 2026-03-31 | -183.32% |
| 2025-12-31 | -245.48% |
| 2025-09-30 | -46.40% |
| 2025-06-30 | -632.75% |
| 2025-03-31 | -68.51% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
